BRAINTREE, Mass., Nov. 8 /PRNewswire-FirstCall/ -- Haemonetics Corporation is pleased to announce that Mikael Gordon will join the company effective November 12, 2007 as President of Haemonetics Europe. Mr. Gordon will have responsibility for European operations, including sales and marketing, services, finance and human resources and will be based at the company’s European Headquarters in Signy, Switzerland. He will also join Haemonetics’ global Operating Committee.
Mr. Gordon has more than 20 years of management experience across broad functions and disciplines, with particular focus in life sciences and healthcare. He was employed in executive management, sales, marketing, strategic planning, and information technology positions during his ten year career at Amersham Pharmacia and later GE Healthcare when it acquired Amersham. Most recently, Mr. Gordon was Regional Executive Manager, North and West Europe for GE Healthcare Clinical Systems, which provides hospitals with anesthesia, ventilation, and diagnostic cardiology systems and services. Prior to GE Healthcare, he was employed in executive positions with Lagerkvist & Partners AB, BNL Information AB, Industrifinans Service AB, and McCormack and Dodge AB.
Brian Concannon, Haemonetics’ Chief Operating Officer, said, “I am very excited to have someone of Mikael’s capability and background joining our team. Mikael has tremendous experience in managing diverse, multi-national businesses and a consistent track record of building and leading high performing teams. I am confident that he will continue to drive strong results and accelerate growth as we complete our business transformation initiatives in Europe.”
Mr. Gordon, age 52, is a graduate of Stockholm School of Economics and holds a bachelor of science degree in international economics and business administration.
Haemonetics is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com .
fallon@haemonetics.com
CONTACT: Julie Fallon of Haemonetics Corporation, +1-781-356-9517 or
+1-617-320-2401, fallon@haemonetics.com
Web site: http://www.haemonetics.com/
